专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明申请

WO2011086356A1 ANTI SIPHON DEVICE 审中-公开
标题翻译： ANTI SIPHON设备
公开(公告)号：WO2011086356A1
公开(公告)日：2011-07-21
申请号：PCT/GB2011/000044
申请日：2011-01-14
申请人： TISS LIMITED , FOSTER, Richard , WHOLEY, Ryan
发明人： FOSTER, Richard , WHOLEY, Ryan
IPC分类号： B60K15/04
CPC分类号： B60K15/0403 , Y10T137/3149
摘要： An anti siphon device, comprises a generally tubular body (1) having a longitudinal axis X; an outlet (18). The anti siphon device comprises an inlet; the inlet having an opening adapted to receive a fuel dispensing nozzle (19) the end of which has an outside diameter D, the inlet having a constriction (11a) spaced from said opening along said axis X and having a diameter d less than D. The anti siphon device additionally comprises an obstruction (3), at least a major portion of which is located between the constriction (11a) and the outlet (18). The obstruction (3) tapers outwardly relative to the axis X in a direction from the constriction (11a) to the outlet (18). There is provided a flow passageway (17) extending from the constriction (11a) to the outlet (18) and defined between the obstruction (3) and a wall surface (10b) at least substantially surrounding the obstruction (3), the flow passageway (17) having a minimum width less than the diameter d of the constriction (11a). At least a portion of the inlet is defined by a wall surface (10a) which tapers inwardly in the direction of said axis X to said constriction (11a) and is adapted to support the end of the fuel dispensing nozzle (19).
摘要翻译：防虹吸装置包括具有纵向轴线X的大体上管状的主体（1）; 出口（18）。防虹吸装置包括入口; 所述入口具有适于容纳其端部具有外径D的燃料分配喷嘴（19）的开口，所述入口具有沿着所述轴线X与所述开口间隔开并且具有小于D的直径d的收缩部（11a）。防虹吸装置还包括阻塞物（3），其至少大部分位于收缩部（11a）和出口（18）之间。障碍物（3）在从收缩部（11a）到出口（18）的方向上相对于轴线X向外逐渐变细。设置有从收缩部（11a）延伸到出口（18）并且限定在障碍物（3）和至少基本上围绕障碍物（3）的壁表面（10b）之间的流动通道（17），流动通道（17）具有小于收缩部（11a）的直径d的最小宽度。入口的至少一部分由壁表面（10a）限定，壁表面（10a）在所述轴线X的方向向内缩小到所述收缩部分（11a），并且适于支撑燃料分配喷嘴（19）的端部。

2. 发明申请

WO2003062206A2 SMALL MOLECULE MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO 审中-公开
标题翻译：用于预防和治疗相关疾病的5-HT2A丝氨酸受体的小分子调节剂
公开(公告)号：WO2003062206A2
公开(公告)日：2003-07-31
申请号：PCT/US2003/002059
申请日：2003-01-23
申请人： ARENA PHARMACEUTICALS, INC. , TEEGARDEN, Bradley , DROUET, Keith , JAYAKUMAR, Honnappa , THOMSEN, William , MAFFUID, Paul , ELWELL, Katie , FOSTER, Richard , LAWLESS, Michael , LIU, Qian , SMITH, Julian , FEICHTINGER, Konrad
发明人： TEEGARDEN, Bradley , DROUET, Keith , JAYAKUMAR, Honnappa , THOMSEN, William , MAFFUID, Paul , ELWELL, Katie , FOSTER, Richard , LAWLESS, Michael , LIU, Qian , SMITH, Julian , FEICHTINGER, Konrad
IPC分类号： C07D231/16
CPC分类号： C07D231/12 , C07D231/14 , C07D231/16 , C07D401/12 , C07D409/04
摘要： The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the 5-HT 2A serotonin receptor. Formula (I): Compounds and pharmaceutical compositions thereof are directed to methods useful in the prophylaxis or treatment of reducing platelet aggreagation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia and NOS schizophrenia and related disorders. The present invention also relates to the method of prophylaxis or treatment of 5-HT 2A serotonin receptor mediated disorders in combination with a dopamine D2 receptor antagonist such as haloperidol, administered separately or together.
摘要翻译：本发明涉及式（I）的某些吡唑衍生物及其药物组合物，其调节5-HT2Ba5-5羟色胺受体的活性。式（I）：其化合物及其药物组合物涉及可用于预防或治疗减少血小板凝集，冠状动脉疾病，心肌梗塞，短暂性脑缺血发作，心绞痛，中风，心房颤动，降低血凝块形成风险的方法，哮喘或其症状，激动或症状，行为障碍，药物诱导的精神病，兴奋性精神病，杜勒氏综合征，躁狂症，有机或NOS精神病，精神病，精神病，急性精神分裂症，慢性精神分裂症和NOS精神分裂症及相关障碍。本发明还涉及与单独或一起施用的多巴胺D2受体拮抗剂如氟哌啶醇组合预防或治疗5-HT2,5α血清素受体介导的病症的方法。

3. 发明申请

WO2021078991A1 TREATMENT OF CONDITIONS OF THE NERVOUS SYSTEM 审中-公开
公开(公告)号：WO2021078991A1
公开(公告)日：2021-04-29
申请号：PCT/EP2020/079979
申请日：2020-10-25
申请人： KWOK, Jessica , FOSTER, Richard , DUNCAN, James
发明人： KWOK, Jessica , FOSTER, Richard , DUNCAN, James
IPC分类号： A61K31/37 , A61P25/00 , A61P25/16 , A61P25/28
摘要： Provided is 4-methylumbelliferone, derivatives and salts thereof, or a composition comprising same for use in the treatment of a condition of the nervous system in a subject. Preferably, the condition is one associated with a scar, such as a glial scar. Typically, the condition of the nervous system is selected from the group comprising conditions caused by trauma, injury, infection, degeneration, structural defects, tumours, blood flow disruption. The neural and other lesions are made permeable and repairable.

4. 发明申请

WO2016038363A1 ANTIFOULING COMPOSITION 审中-公开
标题翻译：抗反应组合物
公开(公告)号：WO2016038363A1
公开(公告)日：2016-03-17
申请号：PCT/GB2015/052605
申请日：2015-09-09
申请人： FOSTER, Richard
发明人： FOSTER, Richard
IPC分类号： C09D5/16
CPC分类号： C09D5/1618 , C08K2003/085 , C09D7/61
摘要： An antifouling composition is provided, the composition comprising a copper antifouling agent; and a resin binder matrix comprising a hydrophilic resin component and a hydrophobic resin component. A composition for applying to a surface to provide an antifouling coating thereon is also provided, the composition comprising a resin composition comprising a copper antifouling agent; a hydrophilic resin precursor; a hydrophobic resin precursor; and a hardener composition; in use the resin composition and the hardener composition being combined, whereby the hydrophobic resin precursor and the hydrophilic resin precursor react with the hardener composition to form a resin matrix containing the copper antifouling agent. A method of preparing an antifouling coating containing a copper antifouling agent comprises determining the leaching rate of copper antifouling agent required for the coating; providing a mixture comprising the copper antifouling agent, a hydrophobic resin component and a hydrophilic resin component, the ratio of the hydrophobic resin component and the hydrophilic resin component being selected to achieve the determined leaching rate; and curing the mixture.
摘要翻译：提供防污组合物，该组合物包含铜防污剂; 以及包含亲水性树脂成分和疏水性树脂成分的树脂粘合剂基质。还提供了一种用于施加到表面以在其上提供防污涂层的组合物，该组合物包含含有铜防污剂的树脂组合物; 亲水性树脂前体; 疏水性树脂前体; 和硬化剂组合物; 在使用中，组合树脂组合物和固化剂组合物，由此疏水性树脂前体和亲水性树脂前体与固化剂组合物反应，形成含有铜防污剂的树脂基质。制备含有铜防污剂的防污涂料的方法包括测定涂布所需的铜防污剂的浸出速率; 提供包含铜防污剂，疏水性树脂成分和亲水性树脂成分的混合物，选择疏水性树脂成分和亲水性树脂成分的比例，以达到确定的浸出率; 并固化混合物。

5. 发明申请

WO2006014405A3 SULFONAMIDE-BASED COMPOUNDS AS PROTEIN TYROSINE KINASE INHIBITORS 审中-公开
公开(公告)号：WO2006014405A3
公开(公告)日：2006-02-09
申请号：PCT/US2005/023751
申请日：2005-06-30
申请人： BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM , BUDDE, Raymond, A. , THRASH, Thomas , SMITH, Julian , FOSTER, Richard , LIU, Qian , LAWLESS, Michael, S.
发明人： BUDDE, Raymond, A. , THRASH, Thomas , SMITH, Julian , FOSTER, Richard , LIU, Qian , LAWLESS, Michael, S.
IPC分类号： A61K31/635 , A61K31/47 , A61K31/44 , A61K31/415 , A61K31/335 , A61K31/195 , A61K31/17 , A61K31/18 , C07D295/12 , C07D215/14 , C07D213/46 , C07D235/14 , C07D235/24 , C07D233/61 , C07D333/34 , C07C275/36 , C07C309/32 , C07C309/30
摘要： Various sulfonamide-based compounds are able to selectively inhibit the Src family of tyrosine kinases. These compounds are useful in the treatment of various diseases including hyperproliferative diseases, hematologic diseases, osteoporosis, neurological diseases, autoimmune diseases, allergic/irnmunological diseases, or viral infections.

6. 发明申请

WO2003062206A3 SMALL MOLECULE MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO 审中-公开
公开(公告)号：WO2003062206A3
公开(公告)日：2003-07-31
申请号：PCT/US2003/002059
申请日：2003-01-23
申请人： ARENA PHARMACEUTICALS, INC. , TEEGARDEN, Bradley , DROUET, Keith , JAYAKUMAR, Honnappa , THOMSEN, William , MAFFUID, Paul , ELWELL, Katie , FOSTER, Richard , LAWLESS, Michael , LIU, Qian , SMITH, Julian , FEICHTINGER, Konrad
发明人： TEEGARDEN, Bradley , DROUET, Keith , JAYAKUMAR, Honnappa , THOMSEN, William , MAFFUID, Paul , ELWELL, Katie , FOSTER, Richard , LAWLESS, Michael , LIU, Qian , SMITH, Julian , FEICHTINGER, Konrad
IPC分类号： C07D231/16
摘要： The present invention relates to certain pyrazole derivatives of Formula (I) and pharmaceutical compositions thereof that modulate the activity of the 5-HT 2A serotonin receptor. Formula (I): Compounds and pharmaceutical compositions thereof are directed to methods useful in the prophylaxis or treatment of reducing platelet aggreagation, coronary artery disease, myocardial infarction, transient ischemic attack, angina, stroke, atrial fibrillation, reducing the risk of blood clot formation, asthma or symptoms thereof, agitation or a symptom, behavioral disorders, drug induced psychosis, excitative psychosis, Gilles de la Tourette's syndrome, manic disorder, organic or NOS psychosis, psychotic disorder, psychosis, acute schizophrenia, chronic schizophrenia and NOS schizophrenia and related disorders. The present invention also relates to the method of prophylaxis or treatment of 5-HT 2A serotonin receptor mediated disorders in combination with a dopamine D2 receptor antagonist such as haloperidol, administered separately or together.

7. 发明申请

WO2008157751A3 SUBSTITUTED IMIDAZOHETEROCYCLES 审中-公开
公开(公告)号：WO2008157751A3
公开(公告)日：2008-12-24
申请号：PCT/US2008/067632
申请日：2008-06-20
申请人： CARA THERAPEUTICS, INC. , BECKETT, R., Paul , FOSTER, Richard , HENAULT, Christelle , RALBOVSKY, Janet, L. , GAUSS, Carla, M. , GUSTAFSON, Gary, R. , LUO, Zhiyong , CAMPBELL, Ann-marie , SHELEKHIN, Tatiana, E.
发明人： BECKETT, R., Paul , FOSTER, Richard , HENAULT, Christelle , RALBOVSKY, Janet, L. , GAUSS, Carla, M. , GUSTAFSON, Gary, R. , LUO, Zhiyong , CAMPBELL, Ann-marie , SHELEKHIN, Tatiana, E.
IPC分类号： A61K31/70 , C07H19/16 , C07H17/02
摘要： The present invention provides substituted imidazoheterocyclic compounds having the structure of Formula (I) Also provided are pharmaceutically acceptable salts, acid salts, hydrates, solvates and stereoisomers of the compounds of formula I. The compounds are useful as modulators of cannabinoid receptors and for the prophylaxis and treatment of cannabinoid receptor- associated diseases and conditions, such as pain, inflammation and pruritis.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式